Trisura Group Ltd. (TSX:TSU)

Market Cap	2.03B
Revenue (ttm)	3.19B
Net Income (ttm)	121.46M
Shares Out	47.80M
EPS (ttm)	2.50
PE Ratio	17.02
Forward PE	13.55
Dividend	n/a
Ex-Dividend Date	n/a

Volume	27,421
Average Volume	73,877
Open	42.53
Previous Close	42.54
Day's Range	42.12 - 43.08
52-Week Range	30.77 - 46.26
Beta	0.65
RSI	48.43
Earnings Date	Aug 7, 2025

About Achilles Therapeutics

Trisura Group Ltd., a specialty insurance company, operates in the surety, risk solutions, corporate insurance, and reinsurance businesses in Canada, the United States, and internationally. The company operates through two segments: Trisura Canada and Trisura the United States. It also offers risk solutions, fronting, and insurance products, as well as provides business underwriting services. In addition, the company offers contract surety bonds, such as performance, and labor and material payment bonds primarily for the suppliers, manufacturer...

• Industry: Insurance - Specialty
• Sector: Financials
• Founded: 2006
• Employees: 159
• Stock Exchange: Toronto Stock Exchange
• Ticker Symbol: TSU

Financial Performance

In 2024, Trisura Group's revenue was 3.16 billion, an increase of 12.79% compared to the previous year's 2.80 billion. Earnings were 118.92 million, an increase of 77.64%.